Kathleen M. Hayden, Ph.D. - Publications

Affiliations: 
2004 Johns Hopkins University, Baltimore, MD 
Area:
Mental Health, Epidemiology

128 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Shadyab AH, McEvoy LK, Horvath S, Whitsel EA, Rapp SR, Espeland MA, Resnick SM, Manson JE, Chen JC, Chen BH, Li W, Hayden KM, Bao W, Kusters CDJ, LaCroix AZ. Association of Epigenetic Age Acceleration with Incident Mild Cognitive Impairment and Dementia Among Older Women. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 34417803 DOI: 10.1093/gerona/glab245  0.339
2021 Schaich CL, Yeboah J, Espeland MA, Baker LD, Ding J, Hayden KM, Sachs BC, Craft S, Rapp SR, Luchsinger JA, Fitzpatrick AL, Heckbert SR, Post WS, Burke GL, Allen NB, et al. Association of Vascular Risk Scores and Cognitive Performance in a Diverse Cohort: The Multi-Ethnic Study of Atherosclerosis. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 34216214 DOI: 10.1093/gerona/glab189  0.33
2021 Schaich CL, Yeboah J, Espeland MA, Baker LD, Ding J, Hayden KM, Sachs BC, Craft S, Rapp SR, Luchsinger JA, Fitzpatrick AL, Heckbert SR, Post WS, Burke GL, Allen NB, et al. Association of Vascular Risk Scores and Cognitive Performance in a Diverse Cohort: The Multi-Ethnic Study of Atherosclerosis. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 34216214 DOI: 10.1093/gerona/glab189  0.33
2020 Carmichael OT, Neiberg RH, Dutton GR, Hayden KM, Horton E, Pi-Sunyer FX, Johnson KC, Rapp SR, Spira AP, Espeland MA. Long-term change in physiological markers and cognitive performance in type 2 diabetes: the Look AHEAD Study. The Journal of Clinical Endocrinology and Metabolism. PMID 32845968 DOI: 10.1210/Clinem/Dgaa591  0.343
2020 Chlebowski RT, Rapp S, Aragaki AK, Pan K, Neuhouser ML, Snetselaar LG, Manson JE, Wactawski-Wende J, Johnson KC, Hayden K, Baker LD, Henderson VW, Garcia L, Qi L, Prentice RL. Low-fat dietary pattern and global cognitive function: Exploratory analyses of the Women's Health Initiative (WHI) randomized Dietary Modification trial. Eclinicalmedicine. 18: 100240. PMID 31938786 DOI: 10.1016/J.Eclinm.2019.100240  0.374
2020 Lee CM, Woodward M, Batty GD, Beiser AS, Bell S, Berr C, Bjertness E, Chalmers J, Clarke R, Dartigues JF, Davis-Plourde K, Debette S, Di Angelantonio E, Feart C, Frikke-Schmidt R, ... ... Hayden KM, et al. Association of anthropometry and weight change with risk of dementia and its major subtypes: A meta-analysis consisting 2.8 million adults with 57 294 cases of dementia. Obesity Reviews : An Official Journal of the International Association For the Study of Obesity. PMID 31898862 DOI: 10.1111/Obr.12989  0.353
2020 Schaich CL, Bancks M, Ding J, Hayden KM, Heckbert S, Hughes TM, Rapp SR, Fitzpatrick AL, Bertoni AG, Mongraw-Chaffin M. Abstract P349: Association of Lower Fasting Glucose and Visit-to-visit Glucose Variability With Cognitive Performance: The Multi-ethnic Study of Atherosclerosis Circulation. 141. DOI: 10.1161/Circ.141.Suppl_1.P349  0.38
2020 Casanova R, Hayden KM, Barnard R, Anderson A, Hsu F, Talluri R, Whitlow CT, Griswold ME, Hughes TM, Gottesman RF, Wagenknecht LE. Investigating associations of an MRI‐based measure of Alzheimer’s disease neuroanatomic risk with incident cognitive impairment and β‐amyloid burden across race and sex in the ARIC cohort Alzheimer's & Dementia. 16. DOI: 10.1002/alz.040984  0.344
2020 Hayden KM, Leng XI, Manson JE, Desai P, Kitzman J, Jaiswal S, Whitsel EA, Reiner AP. Clonal Hematopoiesis of indeterminate potential and the risk of mild cognitive impairment or probable dementia in the Women’s Health Initiative Memory Study Alzheimer's & Dementia. 16. DOI: 10.1002/alz.039121  0.318
2019 Hayden KM, Gaussoin SA, Hunter JC, Manson JE, Sachs BC, Shadyab AH, Tindle HA, Mossavar-Rahmani Y, Mozhui K, Snively BM, Rapp SR, Resnick SM. Cognitive resilience among APOE ε4 carriers in the oldest old. International Journal of Geriatric Psychiatry. PMID 31418472 DOI: 10.1002/Gps.5199  0.389
2019 Kuchibhatla M, Hunter JC, Plassman BL, Lutz MW, Casanova R, Saldana S, Hayden KM. The association between neighborhood socioeconomic status, cardiovascular and cerebrovascular risk factors, and cognitive decline in the Health and Retirement Study (HRS). Aging & Mental Health. 1-8. PMID 31018653 DOI: 10.1080/13607863.2019.1594169  0.407
2019 Petkus AJ, Resnick SM, Rapp SR, Espeland MA, Gatz M, Widaman KF, Wang X, Younan D, Casanova R, Chui H, Barnard RT, Gaussoin S, Goveas JS, Hayden KM, Henderson VW, et al. General and domain-specific cognitive reserve, mild cognitive impairment, and dementia risk in older women. Alzheimer's & Dementia (New York, N. Y.). 5: 118-128. PMID 31011622 DOI: 10.1016/J.Trci.2019.02.003  0.432
2019 Alber J, Alladi S, Bae HJ, Barton DA, Beckett LA, Bell JM, Berman SE, Biessels GJ, Black SE, Bos I, Bowman GL, Brai E, Brickman AM, Callahan BL, Corriveau RA, ... ... Hayden KM, et al. White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities. Alzheimer's & Dementia (New York, N. Y.). 5: 107-117. PMID 31011621 DOI: 10.1016/J.Trci.2019.02.001  0.469
2019 Handing E, Leng I, Hayden K, Rosano C, Kritchevsky S. Predictors Of Concomitant Cognitive And Physical Function Decline: Results From The Health Abc Study Innovation in Aging. 3. DOI: 10.1093/Geroni/Igz038.303  0.378
2019 Hayden KM, Leng XI, Rapp SR, Shumaker SA, Espeland MA, Weitlauf J, Wallace RB. P1-289: SUBJECTIVE COGNITIVE IMPAIRMENT AND ANOSOGNOSIA IN THE WOMEN'S HEALTH INITIATIVE MEMORY STUDY Alzheimer's & Dementia. 15: P353-P354. DOI: 10.1016/J.Jalz.2019.06.844  0.375
2019 Welsh-Bohmer KA, Atkins AS, Plassman BL, Khan A, Chiang C, Culp M, O'Neil J, Walter R, Haneline S, Arbuckle J, Brewster S, Maruyama Y, Swanson T, Hayden KM, Romero H, et al. O4-11-02: DEFINING COGNITION IN PRE-DEMENTIA CLINICAL TRIALS: BASELINE NEUROPSYCHOLOGICAL DATA FROM THE TOMMORROW STUDY Alzheimer's & Dementia. 15: P1262-P1262. DOI: 10.1016/J.Jalz.2019.06.4801  0.402
2019 Handing EP, Leng XI, Hayden KM, Kritchevsky SB, Craft S. P1-539: Relationship Between Cognitive And Physical Function In Older Adults Across Multiple Studies: A Pooled Analysis Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.1144  0.355
2019 Sachs BC, Hughes TM, Casanova R, Espeland MA, Fischer E, Hayden KM, Rapp SR, Webb AN, Craft S. P1-469: Algorithmic Identification Of Cognitive Impairment Using The Udsv3 Battery Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.1074  0.376
2019 Gu X, Koch M, Tabung FK, Marchand N, Harrington LB, Shadyab AH, Zaslavsky O, Sachs BC, Li W, Johnson KC, Snetselaar LG, Wactawski-Wende J, Rapp SR, Resnick SM, Haring B, ... Hayden KM, et al. THE EMPIRICAL INFLAMMATORY DIETARY PATTERN IN RELATION TO COGNITIVE FUNCTION AND RISK OF MILD COGNITIVE IMPAIRMENT AND DEMENTIA IN THE WOMEN’S HEALTH INITIATIVE MEMORY STUDY Alzheimer's & Dementia. 15: P233-P234. DOI: 10.1016/J.Jalz.2019.06.035  0.439
2018 Deal JA, Goman AM, Albert MS, Arnold ML, Burgard S, Chisolm T, Couper D, Glynn NW, Gmelin T, Hayden KM, Mosley T, Pankow JS, Reed N, Sanchez VA, Richey Sharrett A, et al. Hearing treatment for reducing cognitive decline: Design and methods of the Aging and Cognitive Health Evaluation in Elders randomized controlled trial. Alzheimer's & Dementia (New York, N. Y.). 4: 499-507. PMID 30364572 DOI: 10.1016/J.Trci.2018.08.007  0.411
2018 Espeland MA, Carmichael O, Yasar S, Hugenschmidt C, Hazzard W, Hayden KM, Rapp SR, Neiberg R, Johnson KC, Hoscheidt S, Mielke MM. Sex-related differences in the prevalence of cognitive impairment among overweight and obese adults with type 2 diabetes. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 14: 1184-1192. PMID 30201101 DOI: 10.1016/J.Jalz.2018.05.015  0.536
2018 Mielke MM, Ferretti MT, Iulita MF, Hayden K, Khachaturian AS. Sex and gender in Alzheimer's disease - Does it matter? Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 14: 1101-1103. PMID 30196887 DOI: 10.1016/J.Jalz.2018.08.003  0.496
2018 Casanova R, Barnard R, Gaussoin S, Saldana S, Hayden K, Manson JE, Wallace R, Rapp SR, Resnick SM, Espeland MA, Chen JC. Using high-dimensional machine learning methods to estimate an anatomical risk factor for Alzheimer's disease across imaging databases. Neuroimage. PMID 30130645 DOI: 10.1016/J.Neuroimage.2018.08.040  0.387
2018 Romero HR, Monsch AU, Hayden KM, Plassman BL, Atkins AS, Keefe RSE, Brewster S, Chiang C, O'Neil J, Runyan G, Atkinson MJ, Crawford S, Budur K, Burns DK, Welsh-Bohmer KA. TOMMORROW neuropsychological battery: German language validation and normative study. Alzheimer's & Dementia (New York, N. Y.). 4: 314-323. PMID 30094331 DOI: 10.1016/J.Trci.2018.06.009  0.399
2018 Espeland MA, Chen JC, Weitlauf J, Hayden KM, Rapp SR, Resnick SM, Garcia L, Cannell B, Baker LD, Sachs BC, Tindle HA, Wallace R, Casanova R. Trajectories of Relative Performance with 2 Measures of Global Cognitive Function. Journal of the American Geriatrics Society. PMID 29972592 DOI: 10.1111/Jgs.15431  0.389
2018 Hayden KM, Inouye SK, Cunningham C, Jones RN, Avidan M, Davis D, Kuchel G, Khachaturian AS. Reduce the burden of dementia now. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29959910 DOI: 10.1016/J.Jalz.2018.06.3039  0.369
2018 Khachaturian AS, Hayden KM, Mielke MM, Tang Y, Lutz MW, Gold M, Kukull WA, Mohs R, Gauthier S, Molinuevo JL, Zetterberg H, Khachaturian ZS. New thinking about thinking, part two. Theoretical articles for Alzheimer's & Dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29842864 DOI: 10.1016/J.Jalz.2018.05.002  0.512
2018 Khachaturian AS, Hayden KM, Mielke MM, Tang Y, Lutz MW, Gustafson DR, Kukull WA, Mohs R, Khachaturian ZS. Future prospects and challenges for Alzheimer's disease drug development in the era of the NIA-AA Research Framework. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 14: 532-534. PMID 29653605 DOI: 10.1016/J.Jalz.2018.03.003  0.473
2018 Ong KL, Morris MJ, McClelland RL, Hughes TM, Maniam J, Fitzpatrick AL, Martin SS, Luchsinger JA, Rapp SR, Hayden KM, Sandfort V, Allison MA, Rye KA. Relationship of Lipids and Lipid-Lowering Medications With Cognitive Function: The Multi-Ethnic Study of Atherosclerosis. American Journal of Epidemiology. 187: 767-776. PMID 29617947 DOI: 10.1093/Aje/Kwx329  0.339
2018 Hayden KM, Baker LD, Bray G, Carvajal R, Demos-McDermott K, Hergenroeder AL, Hill JO, Horton E, Jakicic JM, Johnson KC, Neiberg RH, Rapp SR, Wadden TA, Miller ME. Long-term impact of intensive lifestyle intervention on cognitive function assessed with the National Institutes of Health Toolbox: The Look AHEAD study. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 41-48. PMID 29159267 DOI: 10.1016/J.Dadm.2017.09.002  0.377
2018 DUTTON GR, ESPELAND M, NEIBERG RH, CARMICHAEL O, HAYDEN KM, JOHNSON KC, JEFFERY RW, BAKER LD, COOK D, KITZMAN D, RAPP SR. Impact of Intensive Lifestyle Intervention for Weight Management on Self-Reported Cognitive Function—The Action for Health in Diabetes (Look AHEAD) Randomized Controlled Trial Diabetes. 67: 817-P. DOI: 10.2337/Db18-817-P  0.328
2018 Handing E, Leng I, Hayden K, Rosano C, Harris TB, Kritchevsky SB. Cognitive And Physical Function Trajectories Associated With Mortality: Results From The Health Abc Study Innovation in Aging. 2: 604-604. DOI: 10.1093/Geroni/Igy023.2246  0.362
2018 Espeland M, Chen J, Weitlauf J, Hayden K, Rapp S, Resnick S, Garcia L, Casanova R. TRAJECTORIES OF RELATIVE PERFORMANCE ACROSS TWO MEASURES OF GLOBAL COGNITIVE FUNCTION Innovation in Aging. 2: 508-508. DOI: 10.1093/Geroni/Igy023.1887  0.373
2018 Lin FR, Chisolm T, Couper D, Glynn NW, Hayden KM, Mosley TH, Pankow J, Coresh J, Team AS. P1-649: Design Of The Aging And Cognitive Health Evaluation In Elders (Achieve) Randomized Controlled Trial Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.661  0.36
2018 Espeland MA, Carmichael OT, Yasar S, Hugenschmidt CE, Hazzard W, Hayden KM, Rapp SR, Neiberg RH, Johnson KC, Hoscheidt SM, Mielke MM. P1-624: Sex-Related Differences In Cognitive Impairment Among Overweight And Obese Adults With Type 2 Diabetes Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.637  0.505
2018 Hughes TM, Hayden KM, Rapp SR, Baker LD, Sachs BC, Ding J, Craft S, Luchsinger JA, Heckbert S, Post W, Fitzpatrick AL, Burke GL. O3-11-05: Antecedent Vascular Risk Scores And Cognitive Function And Decline: The Multi-Ethnic Study Of Atherosclerosis Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2835  0.413
2018 Ding J, Lohman K, Reynolds LR, Rapp SR, Hughes TM, Hayden KM, Sachs BC, Wilson VM, Molina AJ, Hoeschele I, Liu Y. P3-115: The Associations Of Age-Related Transcriptional Networks With Vascular And Cognitive Function: The Multi-Ethnic Study Of Atherosclerosis Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1472  0.375
2018 Petkus AJ, Espeland MA, Casanova R, Wang X, Younan D, Rapp SR, Chui HC, Hayden KM, Gatz M, Gaussoin SA, Barnard R, Saldana S, Shumaker SA, Chen J. P2-617: Memory Reserve Moderates The Association Between A Neuroanatomical Measure Of Ad Risk And Global Cognitive Decline In The Women'S Health Initiative Memory Study Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1313  0.397
2018 Chiang C, Alexander R, Welsh-Bohmer KA, Plassman BL, Romero H, Hayden KM, Keefe RS, Atkins AS, Harrigan P, O'Neil J, Culp M, Walter R, Wu J, Randle L, Haneline S, et al. P1-050: Adjudicating Mild Cognitive Impairment Due To Alzheimer'S Disease As A Novel Endpoint Event In The Tommorrow Study: A Delay-Of-Onset Phase 3 Clinical Trial Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.051  0.425
2017 Leng X, Espeland MA, Manson JE, Stefanick ML, Gower EW, Hayden KM, Limacher MC, Vaughan L, Robinson J, Wallace R, Wassertheil-Smoller S, Yaffe K, Shumaker SA. Cognitive Function and Changes in Cognitive Function as Predictors of Incident Cardiovascular Disease: The Women's Health Initiative Memory Study. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 28977360 DOI: 10.1093/Gerona/Glx138  0.438
2017 Espeland MA, Carmichael O, Hayden K, Neiberg RH, Newman AB, Keller JN, Wadden TA, Rapp SR, Hill JO, Horton ES, Johnson KC, Wagenknecht L, Wing RR. Long-term Impact of Weight Loss Intervention on Changes in Cognitive Function: Exploratory Analyses from the Action for Health in Diabetes Randomized Controlled Clinical Trial. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 28958022 DOI: 10.1093/Gerona/Glx165  0.365
2017 Hayden KM, Beavers DP, Steck SE, Hebert JR, Tabung FK, Shivappa N, Casanova R, Manson JE, Padula CB, Salmoirago-Blotcher E, Snetselaar LG, Zaslavsky O, Rapp SR. The association between an inflammatory diet and global cognitive function and incident dementia in older women: The Women's Health Initiative Memory Study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28531379 DOI: 10.1016/J.Jalz.2017.04.004  0.448
2017 Hughes TM, Craft S, Baker LD, Espeland MA, Rapp SR, Sink KM, Bertoni AG, Burke GL, Gottesman RF, Michos ED, Luchsinger JA, Fitzpatrick AL, Hayden KM. Changes in metabolic risk factors over 10 years and their associations with late-life cognitive performance: The Multi-Ethnic Study of Atherosclerosis. Alzheimer's & Dementia (Amsterdam, Netherlands). 8: 18-25. PMID 28435852 DOI: 10.1016/J.Dadm.2017.03.003  0.386
2017 Corrada MM, Hayden KM, Paganini-Hill A, Bullain SS, DeMoss J, Aguirre C, Brookmeyer R, Kawas CH. Age of onset of hypertension and risk of dementia in the oldest-old: The 90+ Study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28108119 DOI: 10.1016/J.Jalz.2016.09.007  0.366
2017 Romero HR, Zhao S, Perez M, Bougard C, Montero J, Smith R, Welsh-Bohmer KA, Plassman BL, Hayden KM. Cognitive And Functional Predictors Of Incident Alzheimer'S Disease: Data From The National Alzheimer’S Coordinating Center (Nacc) Alzheimers & Dementia. 13: 884. DOI: 10.1016/J.Jalz.2017.07.278  0.44
2017 Rapp SR, Carmichael OT, Hayden KM, Neiberg RH, Newman AB, Keller JN, Wadden T, Hill JO, Horton ES, Johnson KC, Wagenknecht LE, Wing RR, Espeland MA. Long-Term Impact Of Weight Loss Intervention On Changes In Cognitive Function: Exploratory Analyses From The Action For Health In Diabetes Randomized Controlled Clinical Trial Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.1242  0.309
2017 Hayden KM, Wang Y, Beavers D, Chen J, Espeland MA, Ford CN, Harrington LB, He K, Jensen MK, Johnson KC, Manson JE, Marchand N, Masaki K, Salmoirago-Blotcher E, Vitolins M, et al. [P2-555]: THE MIND DIET AND INCIDENT DEMENTIA: FINDINGS FROM THE WOMEN's HEALTH INITIATIVE MEMORY STUDY Alzheimer's & Dementia. 13: P858-P858. DOI: 10.1016/J.Jalz.2017.06.1213  0.326
2016 Espeland MA, Rapp SR, Manson JE, Goveas JS, Shumaker SA, Hayden KM, Weitlauf JC, Gaussoin SA, Baker LD, Padula CB, Hou L, Resnick SM. Long-term Effects on Cognitive Trajectories of Postmenopausal Hormone Therapy in Two Age Groups. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 27506836 DOI: 10.1093/Gerona/Glw156  0.343
2016 Lutz MW, Sundseth SS, Burns DK, Saunders AM, Hayden KM, Burke JR, Welsh-Bohmer KA, Roses AD. A Genetics-based Biomarker Risk Algorithm for Predicting Risk of Alzheimer's Disease. Alzheimer's & Dementia : Translational Research & Clinical Interventions. 2: 30-44. PMID 27047990 DOI: 10.1016/J.Trci.2015.12.002  0.363
2016 Espeland MA, Rapp SR, Manson JE, Goveas JS, Shumaker SA, Hayden KM, Weitlauf J, Gaussoin SA, Baker LD, Padula CB, Hou L, Resnick SM. O1-08-06: Long Term Effects on Cognitive Trajectories of Early Versus Late Postmenopausal Hormone Therapy Alzheimer's & Dementia. 12: P195-P196. DOI: 10.1016/J.Jalz.2016.06.340  0.334
2016 Hughes TM, Baker LD, Bertoni A, Burke GL, Espeland MA, Casanova R, Gottesman RF, Michos ED, Rapp SR, Hayden KM, Sink KM, Craft S. Changes In Metabolic Risk Factors Over 10 Years And Their Associations With Cognitive Performance: The Multi-Ethnic Study Of Atherosclerosis (Mesa) Alzheimers & Dementia. 12: 1119. DOI: 10.1016/J.Jalz.2016.06.2326  0.39
2016 Casanova R, Hsu F, Saldana S, Lutz MW, Kuchibhatla M, Germain CM, Plassman BL, Hayden KM. P2-244: Investigating Associations between APOE , CD33 with Measures of Alzheimer's Disease Severity Derived from Neuroimaging Data Alzheimer's & Dementia. 12: P718-P718. DOI: 10.1016/J.Jalz.2016.06.1412  0.327
2016 Hayden KM, Beavers D, Steck SE, Hebert JR, Tabung FK, Casanova R, Manson JE, Padula CB, Salmirago-Blotcher E, Snetselaar LG, Zaslavsky O, Rapp SR. P1-386: Impact of Inflammatory Diet on Global Cogntive Function and Incident Dementia in Older Women Alzheimer's & Dementia. 12: P579-P580. DOI: 10.1016/J.Jalz.2016.06.1138  0.324
2015 Hayden KM, Farmer KM. Invited commentary: The importance of studying environmental risk factors for dementia. Alzheimer's & Dementia (Amsterdam, Netherlands). 1: 268-9. PMID 27239509 DOI: 10.1016/J.Dadm.2015.05.001  0.404
2015 Chatterjee S, Peters SA, Woodward M, Arango SM, Batty GD, Beckett N, Beiser A, Borenstein AR, Crane PK, Haan M, Hassing LB, Hayden KM, Kiyohara Y, Larson EB, Li CY, et al. Type 2 Diabetes as a Risk Factor for Dementia in Women Compared With Men: A Pooled Analysis of 2.3 Million People Comprising More Than 100,000 Cases of Dementia. Diabetes Care. PMID 26681727 DOI: 10.2337/Dc15-1588  0.329
2015 Hayden KM, Lutz MW, Kuchibhatla M, Germain C, Plassman BL. Correction: Effect of APOE and CD33 on Cognitive Decline. Plos One. 10: e0134887. PMID 26230933 DOI: 10.1371/Journal.Pone.0134887  0.352
2015 Hayden KM, Lutz MW, Kuchibhatla M, Germain C, Plassman BL. Effect of APOE and CD33 on Cognitive Decline. Plos One. 10: e0130419. PMID 26102276 DOI: 10.1371/Journal.Pone.0130419  0.415
2015 Hayden KM, Lutz MW, Kuchibhatla M, Germain C, Plassman BL. Trajectories of cognitive decline associated with ApoE-e4 and cd33 interaction Alzheimers & Dementia. 11: 770. DOI: 10.1016/J.Jalz.2015.06.1716  0.357
2014 Hayden KM, Makeeva OA, Newby LK, Plassman BL, Markova VV, Dunham A, Romero HR, Melikyan ZA, Germain CM, Welsh-Bohmer KA, Roses AD. A comparison of neuropsychological performance between US and Russia: preparing for a global clinical trial. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 760-768.e1. PMID 25066497 DOI: 10.1016/J.Jalz.2014.02.008  0.308
2014 Chuang YF, Breitner JC, Chiu YL, Khachaturian A, Hayden K, Corcoran C, Tschanz J, Norton M, Munger R, Welsh-Bohmer K, Zandi PP. Use of diuretics is associated with reduced risk of Alzheimer's disease: the Cache County Study. Neurobiology of Aging. 35: 2429-35. PMID 24910391 DOI: 10.1016/J.Neurobiolaging.2014.05.002  0.581
2014 Romero HR, Welsh-Bohmer KA, Gwyther LP, Edmonds HL, Plassman BL, Germain CM, McCart M, Hayden KM, Pieper C, Roses AD. Community engagement in diverse populations for Alzheimer disease prevention trials. Alzheimer Disease and Associated Disorders. 28: 269-74. PMID 24614272 DOI: 10.1097/Wad.0000000000000029  0.348
2014 Hayden KM, Potter GG. More evidence for the benefits of cognitive activity over the lifespan. Evidence-Based Medicine. 19: 114. PMID 24441078 DOI: 10.1136/Eb-2013-101539  0.434
2014 Hayden KM, Kuchibhatla M, Romero HR, Plassman BL, Burke JR, Browndyke JN, Welsh-Bohmer KA. Pre-clinical cognitive phenotypes for Alzheimer disease: a latent profile approach. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 22: 1364-74. PMID 24080384 DOI: 10.1016/J.Jagp.2013.07.008  0.416
2014 Hayden KM, Kawas CH, Bullain SS, DeMoss J, Aguirre C, Corrada MM. P2-085: THE ASSOCIATION BETWEEN MEASURED BLOOD PRESSURE AND INCIDENT DEMENTIA IN THE OLDEST OLD: THE 90+ STUDY Alzheimer's & Dementia. 10: P501-P502. DOI: 10.1016/J.Jalz.2014.05.759  0.305
2014 Espeland MA, Vaughan L, Romero H, Hayden KM, Plassman BL, Welsh-Bohmer KA. P3-398: DERIVING AN INFORMED NEUROCOGNITIVE COMPOSITE MEASURE FOR DELAY-OF-ONSET TRIALS IN MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE (MCI-AD) Alzheimer's & Dementia. 10: P776-P776. DOI: 10.1016/J.Jalz.2014.05.1492  0.447
2014 Atkins AS, Keefe RS, Vaughan AW, Turcotte NM, Makeeva OA, Monsch AU, Frisoni GB, Parapini M, Melikyan ZA, Brewster S, O'Neil J, Schuster J, Lymboura M, Romero H, Hayden KM, et al. P3-255: CULTURAL ADAPTATION OF TRANSLATED NEUROCOGNITIVE ASSESSMENTS IN RUSSIA, SWITZERLAND AND ITALY: PILOT TESTING FOR A PROGRAM TO DELAY THE ONSET OF MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE Alzheimer's & Dementia. 10: P725-P726. DOI: 10.1016/J.Jalz.2014.05.1347  0.41
2014 Hayden KM, Plassman BL, Potter GG, Norton MC, Tschanz JT, Darcey DJ, Zandi PP, Breitner JC, Welsh-Bohmer KA. O4-08-02: THE ASSOCIATION BETWEEN LIFETIME OCCUPATIONAL EXPOSURE TO PESTICIDES AND COGNITIVE DECLINE IN THE ELDERLY Alzheimer's & Dementia. 10: P266-P267. DOI: 10.1016/J.Jalz.2014.04.428  0.572
2013 Peters ME, Rosenberg PB, Steinberg M, Norton MC, Welsh-Bohmer KA, Hayden KM, Breitner J, Tschanz JT, Lyketsos CG. Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: the Cache County Study. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 21: 1116-24. PMID 23567370 DOI: 10.1016/J.Jagp.2013.01.049  0.385
2013 Browndyke JN, Giovanello K, Petrella J, Hayden K, Chiba-Falek O, Tucker KA, Burke JR, Welsh-Bohmer KA. Phenotypic regional functional imaging patterns during memory encoding in mild cognitive impairment and Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 284-94. PMID 22841497 DOI: 10.1016/J.Jalz.2011.12.006  0.366
2013 Plassman B, Germain C, Hayden K, Potter G, Romero H, Welsh-Bohmer K, Burke JR. P4-213: Misdiagnosis using brief cognitive screening instruments in a population-representative sample Alzheimer's & Dementia. 9: P784-P785. DOI: 10.1016/J.Jalz.2013.05.1605  0.362
2013 Hayden K, Kuchibhatla M, Plassman B, Germain C, Romero H, Welsh-Bohmer K. O3-09-02: The use of reliable change indices to complement norms in the early identification of cognitive decline Alzheimer's & Dementia. 9: P535-P536. DOI: 10.1016/J.Jalz.2013.04.286  0.373
2013 Germain C, Dunham A, Makeeva O, Markova V, Zhukova I, Melikyan Z, Zhukova N, Minaycheva L, Buikin S, Abushaeva M, Burlutskaya S, Karas E, Starinskaya E, Maruyama Y, Romero H, ... ... Hayden K, et al. Variations in cognitive performance, demographics and health across community-based registries, from North Carolina to Tomsk, Russia Alzheimers & Dementia. 9: 322-322. DOI: 10.1016/J.Jalz.2013.04.153  0.346
2013 Welsh-Bohmer K, Romero H, Hayden K, Plassman B, Germain C, Sano M, Espeland M, Craft S, Monsch A, Schneider L, Chiang C, Haneline S, Oneil J, Malholtra M, Brannan S, et al. O1-06-01: Challenges in international clinical trials to delay early symptomatic Alzheimer's disease Alzheimer's & Dementia. 9: P137-P138. DOI: 10.1016/J.Jalz.2013.04.079  0.321
2012 Shao H, Breitner JC, Whitmer RA, Wang J, Hayden K, Wengreen H, Corcoran C, Tschanz J, Norton M, Munger R, Welsh-Bohmer K, Zandi PP. Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study. Neurology. 79: 1846-52. PMID 23100399 DOI: 10.1212/Wnl.0B013E318271F823  0.529
2012 Hayden KM, McEvoy JM, Linnertz C, Attix D, Kuchibhatla M, Saunders AM, Lutz MW, Welsh-Bohmer KA, Roses AD, Chiba-Falek O. A homopolymer polymorphism in the TOMM40 gene contributes to cognitive performance in aging. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 8: 381-8. PMID 22863908 DOI: 10.1016/J.Jalz.2011.10.005  0.401
2012 Peters ME, Rosenberg PB, Steinberg M, Tschanz JT, Norton MC, Welsh-Bohmer KA, Hayden KM, Breitner JC, Lyketsos CG. Prevalence of neuropsychiatric symptoms in CIND and its subtypes: the Cache County Study. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 20: 416-24. PMID 22522960 DOI: 10.1097/Jgp.0B013E318211057D  0.368
2012 Hayden KM, Welsh-Bohmer KA. Epidemiology of cognitive aging and Alzheimer's disease: contributions of the cache county utah study of memory, health and aging. Current Topics in Behavioral Neurosciences. 10: 3-31. PMID 21809193 DOI: 10.1007/7854_2011_152  0.422
2012 Makeeva O, Markova V, Zhukova I, Melikyan Z, Minaycheva L, Buikin S, Osinova E, Abushaeva M, Botkina O, Musina N, Starinskaya E, Zhukova N, Maruyama Y, McCart M, MacDonald H, ... ... Hayden K, et al. P4-327: Montreal Cognitive Assessment (MoCA) population-based study of Russian elderly Alzheimer's & Dementia. 8: S773-S773. DOI: 10.1016/J.Jalz.2013.08.108  0.402
2012 Romero H, Hayden K, Plassman B, Welsh-Bohmer K, Burke JR. P3-239: Vascular risk and cognition in the Alzheimer's Disease Prevention Registry Alzheimer's & Dementia. 8: P544-P544. DOI: 10.1016/J.Jalz.2012.05.1461  0.369
2011 Hayden KM, Reed BR, Manly JJ, Tommet D, Pietrzak RH, Chelune GJ, Yang FM, Revell AJ, Bennett DA, Jones RN. Cognitive decline in the elderly: an analysis of population heterogeneity. Age and Ageing. 40: 684-9. PMID 21890481 DOI: 10.1093/Ageing/Afr101  0.434
2011 Hayden KM, Jones RN, Zimmer C, Plassman BL, Browndyke JN, Pieper C, Warren LH, Welsh-Bohmer KA. Factor structure of the National Alzheimer's Coordinating Centers uniform dataset neuropsychological battery: an evaluation of invariance between and within groups over time. Alzheimer Disease and Associated Disorders. 25: 128-37. PMID 21606904 DOI: 10.1097/Wad.0B013E3181Ffa76D  0.448
2011 Mayeux R, Reitz C, Brickman AM, Haan MN, Manly JJ, Glymour MM, Weiss CC, Yaffe K, Middleton L, Hendrie HC, Warren LH, Hayden KM, Welsh-Bohmer KA, Breitner JC, Morris JC. Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 1. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 15-34. PMID 21255741 DOI: 10.1016/J.Jalz.2010.11.005  0.41
2011 Hayden K, Lutz M, Saunders A, Romero H, Burke J, Welsh-Bohmer K, Roses A. P1-235: TOMM40 “523” Genotype Affects Age of Alzheimer's Disease Onset Differentially by Race Alzheimer's & Dementia. 7: S186-S186. DOI: 10.1016/J.Jalz.2011.05.515  0.362
2011 Zandi P, Norton M, Tschanz J, Welsh-Bohmer K, Breitner J, Hayden K, Munger R, Whitmer R, Shao H, Szekely C, Wang J. O1-02-07: Timing and type of hormone replacement therapy and the risk of Alzheimer's disease: New findings from the cache county study Alzheimer's & Dementia. 7: S97-S97. DOI: 10.1016/J.Jalz.2011.05.237  0.49
2011 Tschanz J, Hatch D, Croasdell S, Wanzek J, Kauwe J, Corcoran C, Norton M, Green R, Munger R, Hayden K, Breitner J, Welsh-Bohmer K, Lyketsos C. Family history of non-Alzheimer's Demeutia memory problems predicts rate of cognitive decline in APOE E4 non-carriers in Alzheimer's disease: The Cache County Dementia Progression Study. Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1054  0.421
2010 Hayden KM, Norton MC, Darcey D, Ostbye T, Zandi PP, Breitner JC, Welsh-Bohmer KA. Occupational exposure to pesticides increases the risk of incident AD: the Cache County study. Neurology. 74: 1524-30. PMID 20458069 DOI: 10.1212/Wnl.0B013E3181Dd4423  0.601
2010 Chuang YF, Hayden KM, Norton MC, Tschanz J, Breitner JC, Welsh-Bohmer KA, Zandi PP. Association between APOE epsilon4 allele and vascular dementia: The Cache County study. Dementia and Geriatric Cognitive Disorders. 29: 248-53. PMID 20375505 DOI: 10.1159/000285166  0.588
2010 Welsh-Bohmer KA, Plassman BL, Hayden KM. Genetic and environmental contributions to cognitive decline in aging and Alzheimer's disease Annual Review of Gerontology and Geriatrics. 30: 81-114. DOI: 10.1891/0198-8794.30.81  0.427
2010 Welsh-Bohmer KA, Romero HR, Edmonds HL, McCart MI, Hayden KM, Browndyke JN, Tovar T, Gwyther LP, Burke JR, Roses AD. Community Engagement in Diverse Populations for Alzheimer's Disease Prevention Trials Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.08.073  0.313
2010 Romero HR, Hayden KM, Pieper CF, Sanders L, Welsh-Bohmer KA. P2-144: Improving detection of prodromal Alzheimer's disease in diverse populations Alzheimer's & Dementia. 6: S355-S356. DOI: 10.1016/J.Jalz.2010.05.1191  0.336
2010 Hayden KM, Breitner JCS, Welsh-Bohmer KA. Apolipoprotein E ε4 status and cognitive decline with and without dementia - Reply Archives of Neurology. 67: 1036-1037. DOI: 10.1001/Archneurol.2010.164  0.436
2009 Hayden KM, Zandi PP, West NA, Tschanz JT, Norton MC, Corcoran C, Breitner JC, Welsh-Bohmer KA. Effects of family history and apolipoprotein E epsilon4 status on cognitive decline in the absence of Alzheimer dementia: the Cache County Study. Archives of Neurology. 66: 1378-83. PMID 19901170 DOI: 10.1001/Archneurol.2009.237  0.621
2009 Hulette CM, Ervin JF, Edmonds Y, Antoine S, Stewart N, Szymanski MH, Hayden KM, Pieper CF, Burke JR, Welsh-Bohmer KA. Cerebrovascular smooth muscle actin is increased in nondemented subjects with frequent senile plaques at autopsy: implications for the pathogenesis of Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 68: 417-24. PMID 19287310 DOI: 10.1097/Nen.0B013E31819E6334  0.325
2009 Welsh-Bohmer KA, Ostbye T, Sanders L, Pieper CF, Hayden KM, Tschanz JT, Norton MC. Neuropsychological performance in advanced age: influences of demographic factors and Apolipoprotein E: findings from the Cache County Memory Study. The Clinical Neuropsychologist. 23: 77-99. PMID 18609337 DOI: 10.1080/13854040801894730  0.401
2009 Hayden KM, Norton MC, Darcy D, Ostbye T, Breitner JC, Welsh-Bohmer KA. O3-02-05: Occupational exposure to pesticides increases the risk of Alzheimer's disease: Findings from the Cache County Study Alzheimer's & Dementia. 5: P128-P129. DOI: 10.1016/J.Jalz.2009.05.434  0.355
2009 Hayden KM, Warren LH, Plassman B, Browndyke J, Pieper C, Sanders L, Welsh-Bohmer KA. P4-057: Neuropsychological domains in mild cognitive impairment and normal aging: Results from the NACC UDS study Alzheimer's & Dementia. 5: P448-P448. DOI: 10.1016/J.Jalz.2009.04.826  0.397
2009 Welsh-Bohmer KA, Norton MC, Hayden KM, Østbye T, Pieper CF, Corcoran C, Breitner JCS. Predictors of successful cognitive aging: Findings from the cache county memory study Alzheimers & Dementia. 5: 295. DOI: 10.1016/J.Jalz.2009.04.425  0.374
2009 Munger RG, Charoonruk J, Tschanz J, Zandi P, Corcoran C, Wengreen H, Hayden K, Norton M, Welsh-Bohmer K. P3-154: Prospective study of diabetes and cognitive decline and dementia subtypes in Cache County, Utah, USA Alzheimer's & Dementia. 5: P389-P389. DOI: 10.1016/J.Jalz.2009.04.1028  0.554
2008 Rosenberg PB, Mielke MM, Tschanz J, Cook L, Corcoran C, Hayden KM, Norton M, Rabins PV, Green RC, Welsh-Bohmer KA, Breitner JC, Munger R, Lyketsos CG. Effects of cardiovascular medications on rate of functional decline in Alzheimer disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 16: 883-92. PMID 18978249 DOI: 10.1097/Jgp.0B013E318181276A  0.546
2008 Fotuhi M, Zandi PP, Hayden KM, Khachaturian AS, Szekely CA, Wengreen H, Munger RG, Norton MC, Tschanz JT, Lyketsos CG, Breitner JC, Welsh-Bohmer K. Better cognitive performance in elderly taking antioxidant vitamins E and C supplements in combination with nonsteroidal anti-inflammatory drugs: the Cache County Study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 4: 223-7. PMID 18631971 DOI: 10.1016/J.Jalz.2008.01.004  0.605
2008 Warren LH, Hayden KM, Sanders L, Ostbye T, Pieper CF, Tschanz JT, Norton MC, Hartman M, Welsh-Bohmer KA. P1-174: Stability and prediction of future dementia for multiple transitional cognitive states: The cache county study Alzheimer's & Dementia. 4: T259-T259. DOI: 10.1016/J.Jalz.2008.05.762  0.389
2008 Hayden KM, Zandi PP, West NA, Tschanz JT, Norton MC, Corcoran C, Breitner JC, Welsh-Bohmer KA. O3-03-08: The association between family history of Alzheimer's disease, APOE status, and cognitive decline Alzheimer's & Dementia. 4: T164-T165. DOI: 10.1016/J.Jalz.2008.05.430  0.606
2008 Welsh-Bohmer KA, Hayden KM, Sanders L, Pieper CF, Østbye T, Warren LH, Norton MC, Tschanz JT, Zandi PP, Toohill M, Sassano N, Corcoran C, Leslie C, Steinberg M, Raj P, et al. P4-057: Prevalence of prodromal Alzheimer's disease across late life: Results from the Cache County Study Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.2122  0.55
2007 Mielke MM, Rosenberg PB, Tschanz J, Cook L, Corcoran C, Hayden KM, Norton M, Rabins PV, Green RC, Welsh-Bohmer KA, Breitner JC, Munger R, Lyketsos CG. Vascular factors predict rate of progression in Alzheimer disease. Neurology. 69: 1850-8. PMID 17984453 DOI: 10.1212/01.Wnl.0000279520.59792.Fe  0.539
2007 Hayden KM, Zandi PP, Khachaturian AS, Szekely CA, Fotuhi M, Norton MC, Tschanz JT, Pieper CF, Corcoran C, Lyketsos CG, Breitner JC, Welsh-Bohmer KA. Does NSAID use modify cognitive trajectories in the elderly? The Cache County study. Neurology. 69: 275-82. PMID 17636065 DOI: 10.1212/01.Wnl.0000265223.25679.2A  0.607
2007 Wengreen HJ, Munger RG, Corcoran CD, Zandi P, Hayden KM, Fotuhi M, Skoog I, Norton MC, Tschanz J, Breitner JC, Welsh-Bohmer KA. Antioxidant intake and cognitive function of elderly men and women: the Cache County Study. The Journal of Nutrition, Health & Aging. 11: 230-7. PMID 17508099  0.498
2007 Hayden KM, Welsh-Bohmer KA, Wengreen HJ, Zandi PP, Lyketsos CG, Breitner JC. Risk of mortality with vitamin E supplements: the Cache County study. The American Journal of Medicine. 120: 180-4. PMID 17275460 DOI: 10.1016/J.Amjmed.2006.03.039  0.51
2007 Hayden KM, Tschanz JT, Norton MC, Pieper CF, Ostbye T, Sanders L, Welsh-Bohmer KA. O2-02-02: Early identification of cognitive trajectories with neuropsychological testing. The cache county study Alzheimer's & Dementia. 3: S185-S185. DOI: 10.1016/J.Jalz.2007.04.036  0.308
2006 Welsh-Bohmer KA, Breitner JC, Hayden KM, Lyketsos C, Zandi PP, Tschanz JT, Norton MC, Munger R. Modifying dementia risk and trajectories of cognitive decline in aging: the Cache County Memory Study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 2: 257-60. PMID 19595895 DOI: 10.1016/J.Jalz.2006.04.011  0.639
2006 Tschanz JT, Welsh-Bohmer KA, Lyketsos CG, Corcoran C, Green RC, Hayden K, Norton MC, Zandi PP, Toone L, West NA, Breitner JC. Conversion to dementia from mild cognitive disorder: the Cache County Study. Neurology. 67: 229-34. PMID 16864813 DOI: 10.1212/01.Wnl.0000224748.48011.84  0.619
2006 Hayden KM, Zandi PP, Lyketsos CG, Khachaturian AS, Bastian LA, Charoonruk G, Tschanz JT, Norton MC, Pieper CF, Munger RG, Breitner JC, Welsh-Bohmer KA. Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study. Alzheimer Disease and Associated Disorders. 20: 93-100. PMID 16772744 DOI: 10.1097/01.Wad.0000213814.43047.86  0.572
2006 Khachaturian AS, Zandi PP, Lyketsos CG, Hayden KM, Skoog I, Norton MC, Tschanz JT, Mayer LS, Welsh-Bohmer KA, Breitner JC. Antihypertensive medication use and incident Alzheimer disease: the Cache County Study. Archives of Neurology. 63: 686-92. PMID 16533956 DOI: 10.1001/Archneur.63.5.Noc60013  0.564
2006 Hayden KM, Gaussoin SA, Hunter JC, Manson JE, Sachs BC, Shadyab AH, Tindle H, Mossavar-Rahmani Y, Mozhui K, Snively BM, Rapp SR, Resnick SM. P1-632: CHARACTERISTICS OF COGNITIVE RESILIENCE IN APOE ε4 CARRIERS AGED 80 AND OLDER: THE WOMEN'S HEALTH INITIATIVE MEMORY STUDY Alzheimer's & Dementia. 14: P583-P583. DOI: 10.1016/J.Jalz.2018.06.644  0.392
2006 Carmichael OT, Neiberg RH, Dutton G, Hayden KM, Horton ES, Pi-Sunyer X, Johnson KC, Rapp SR, Spira AP, Espeland MA. O4-06-06: ASSOCIATIONS BETWEEN TEN-YEAR CHANGE IN DIABETES MARKERS AND COGNITIVE PERFORMANCE IN TYPE 2 DIABETES Alzheimer's & Dementia. 14: P1415-P1416. DOI: 10.1016/J.Jalz.2018.06.2944  0.322
2006 Hayden KM, Zandi PP, Khachaturian AS, Pieper CF, Sanders L, Ostbye T, Tschanz JT, Norton MC, Munger R, Lyketsos CG, Breitner JC, Welsh-Bohmer KA. P1-266 Alzheimer's & Dementia. 2: S174. DOI: 10.1016/J.Jalz.2006.05.643  0.473
2006 Fotuhi M, Zandi PP, Hayden KM, Khachaturian AS, Wengreen H, Munger R, Norton MC, Tschanz JT, Lyketsos CG, Breitner JC, Welsh-Bohmer KA. P4-375: APOE-4 positive elderly taking anti-oxidant vitamins E and C in combination with NSAIDs develop less cognitive decline with aging: The Cache County study Alzheimer's & Dementia. 2: S628-S628. DOI: 10.1016/J.Jalz.2006.05.2116  0.567
2005 Hayden KM, Warren LH, Pieper CF, Østbye T, Tschanz JT, Norton MC, Breitner JC, Welsh-Bohmer KA. Identification of VaD and AD prodromes: the Cache County Study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 1: 19-29. PMID 19595812 DOI: 10.1016/J.Jalz.2005.06.002  0.472
2005 Hayden KM, Zandi PP, Lyketsos CG, Tschanz JT, Norton MC, Khachaturian AS, Pieper CF, Welsh-Bohmer KA, Breitner JC. Apolipoprotein E genotype and mortality: findings from the Cache County Study. Journal of the American Geriatrics Society. 53: 935-42. PMID 15935014 DOI: 10.1111/J.1532-5415.2005.53301.X  0.563
2005 Fotuhi M, Zandi P, Hayden KM, Khachaturian AS, Wengreen H, Munger R, Norton MC, Tschanz JT, Breitner JC, Welsh-Bohmer KA. [O2-02-05]: Use of NSAIDs and antioxidant supplements in combination reduces the rate of cognitive decline. The Cache County study Alzheimer's & Dementia. 1: S97-S98. DOI: 10.1016/J.Jalz.2005.06.338  0.572
2005 Hayden KM, Zandi PP, Khachaturian AS, Norton MC, Tschanz JT, Pieper CF, Breitner JC, Welsh-Bohmer KA. [O2-02-04]: Statin use does not reduce cognitive decline in the elderly. The Cache County study Alzheimer's & Dementia. 1: S97-S97. DOI: 10.1016/J.Jalz.2005.06.337  0.588
2005 Hayden KM, Zandi PP, Wengreen HJ, Tschanz JT, Norton MC, Breitner JC, Welsh-Bohmer KA. [O2-01-07]: Does vitamin E use protect against dementia or increase the risk of mortality? Alzheimer's & Dementia. 1: S95-S96. DOI: 10.1016/J.Jalz.2005.06.332  0.538
2005 Charoonruk G, Munger R, Wengreen H, Corcoran C, Hayden K, Bastian L, Tschanz J, Norton M, Welsh-Bohmer K. [O1-01-05]: Diabetes mellitus and risk of Alzheimer's disease in the Cache County study on memory, health, and aging Alzheimer's & Dementia. 1: S78-S78. DOI: 10.1016/J.Jalz.2005.06.280  0.352
2004 Tschanz JT, Corcoran C, Skoog I, Khachaturian AS, Herrick J, Hayden KM, Welsh-Bohmer KA, Calvert T, Norton MC, Zandi P, Breitner JC. Dementia: the leading predictor of death in a defined elderly population: the Cache County Study. Neurology. 62: 1156-62. PMID 15079016 DOI: 10.1212/01.Wnl.0000118210.12660.C2  0.547
2004 Hayden KM, Norton MC, Tschanz JT, Zandi PP, Lyketsos CG, Khachaturian AS, Pieper CF, Welsh-Bohmer KA, Breitner JC. P3-116 The complex role of cardiovascular risk factors, cerebrovascular disease, and gender, with the incidence of Alzheimer's disease: findings from the Cache County Study Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)81268-5  0.562
2004 Norton MC, Steffens DC, Toone L, Tschanz JT, Hayden K, Corcoran C, Klein L, Zandi P, Breitner JC, Welsh-Bohmer KA. P3-108 Late-life depression, mild cognitive impairment, APOE and their interactive effects on conversion to dementia in a population-based study. The Cache County Study Neurobiology of Aging. 25: S385-S386. DOI: 10.1016/S0197-4580(04)81260-0  0.589
2004 Khachaturian AS, Zandi PP, Hayden KM, Lyketsos CG, Mayer LS, Skoog I, Tschanz JT, Norton MC, Welsh-Bohmer KA, Breitner JCS. O3-01-07 Anti-hypertensive medication use may reduce risk of incident Alzheimer's disease. The Cache County Study Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80181-7  0.554
2003 Hayden KM, Khachaturian AS, Tschanz JT, Corcoran C, Nortond M, Breitner JC. Characteristics of a two-stage screen for incident dementia. Journal of Clinical Epidemiology. 56: 1038-45. PMID 14614994 DOI: 10.1016/S0895-4356(03)00247-6  0.313
2002 Zandi PP, Anthony JC, Hayden KM, Mehta K, Mayer L, Breitner JC. Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study. Neurology. 59: 880-6. PMID 12297571 DOI: 10.1212/Wnl.59.6.880  0.508
Show low-probability matches.